Financial Contrast: Lichen China (NASDAQ:LICN) vs. CGI (NYSE:GIB)

Lichen China (NASDAQ:LICNGet Rating) and CGI (NYSE:GIBGet Rating) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, valuation and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Lichen China and CGI, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lichen China 0 0 0 0 N/A
CGI 0 1 1 0 2.50

CGI has a consensus target price of $139.11, suggesting a potential upside of 35.51%. Given CGI’s higher possible upside, analysts plainly believe CGI is more favorable than Lichen China.

Insider & Institutional Ownership

48.5% of CGI shares are owned by institutional investors. 9.9% of CGI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Lichen China and CGI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lichen China N/A N/A N/A
CGI 11.18% 20.81% 10.10%

Earnings and Valuation

This table compares Lichen China and CGI’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lichen China $33.81 million 1.87 N/A N/A N/A
CGI $13.67 billion 1.77 $1.15 billion $4.82 21.30

CGI has higher revenue and earnings than Lichen China.


CGI beats Lichen China on 8 of the 9 factors compared between the two stocks.

About Lichen China

(Get Rating)

Lichen China Limited focuses on providing financial and taxation solution services, education support services, and software and maintenance services under its Lichen brand. Lichen China Limited is based in JINJIANG, China.

About CGI

(Get Rating)

CGI, Inc. engages in the provision of information technology and consulting services. It operates through the following segments: Western and Southern Europe, U.S. Commercial and State Government, Canada, U.S. Federal, Scandinavia and Central Europe, UK and Australia; Finland, Poland, and Baltics, Northwest and Central-East Europe, and Asia Pacific. The company was founded by Serge Godin and Andre Imbeau in June 1976 and is headquartered in Montreal, Canada.

Receive News & Ratings for Lichen China Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lichen China and related companies with's FREE daily email newsletter.